Form 4: REGENXBIO Director Karabelas Exercises Options and Sells Shares
SEC Form 4 Filing
Director Argeris N. Karabelas exercised stock options and sold shares of REGENXBIO Inc. on October 1, 2024, according to a Form 4 filing with the SEC.
Summary
- On October 1, 2024, Argeris N. Karabelas, a director of REGENXBIO Inc., exercised stock options to acquire 10,000 shares of common stock at a price of $3.76 per share.
- Simultaneously, Karabelas sold 10,000 shares of common stock at a weighted average price of $10.1052, with prices ranging from $10.01 to $10.35.
- Following these transactions, Karabelas directly owns 11,286 shares of REGENXBIO Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/19/2015 | 25% of the shares subject to the option vested |
| 10/01/2024 | Director exercised stock options and sold shares |
| 10/02/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.